Novavax(NVAX)
$9.98-0.22 (-2.16%)
NVAX
Novavax Revenue
$9.98
At close:-0.22 (-2.16%)
Want to see NVAX full AI Analyst Report?
Novavax (NVAX) Revenue
10,192 Followers
Novavax Revenue
Novavax had a revenue of 68.30M in the quarter ending Sep 30, 2026, with 20.46%. This bring the company's revenue in the last twelve months to 411.65M, Decreased 0.52%. In the fiscal year ending Dec 31, 2025, Novavax had annual revenue of 1.12B with 64.69% growth.
- Revenue (ttm)
- 411.65M
- Revenue Growth
- -61.33%
- P/S Ratio
- 1.50
- Revenue/Employee
- $1,499,972
- Employees
- 749
- Market Cap
- $1.68B
Revenue Chart
Novavax Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | 441.32M | 64.69% |
| Dec 31, 2024 | 682.16M | 125.78M | 22.61% |
| Dec 31, 2023 | 556.38M | -1.04B | -65.20% |
| Dec 31, 2022 | 1.60B | 1.40B | 709.26% |
| Dec 31, 2021 | 197.58M | 175.19M | 782.53% |
| Dec 31, 2020 | 22.39M | 3.73M | 19.97% |
| Dec 31, 2019 | 18.66M | -15.63M | -45.57% |
| Dec 31, 2018 | 34.29M | 3.11M | 9.98% |
| Dec 31, 2017 | 31.18M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.